TY - JOUR
T1 - Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
AU - Rosengren, Thomas
AU - Nanhoe, Santoesha
AU - de Almeida, Luis Gustavo Dufner
AU - Schönewolf-Greulich, Bitten
AU - Larsen, Lasse Jonsgaard
AU - Hey, Caroline Amalie Brunbjerg
AU - Dunø, Morten
AU - Ek, Jakob
AU - Risom, Lotte
AU - Nellist, Mark
AU - Møller, Lisbeth Birk
PY - 2020/6/18
Y1 - 2020/6/18
N2 - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals out of a cohort of 327 individuals suspected of TSC. A total of 137 predicted pathogenic or likely pathogenic variants were identified: 33 different TSC1 variants in 42 patients, and 104 different TSC2 variants in 126 patients. In 40 cases (24%), the identified predicted pathogenic variant had not been described previously. In total, 33 novel variants in TSC2 and 7 novel variants in TSC1 were identified. To assist in the classification of 11 TSC2 variants, we investigated the effects of these variants in an in vitro functional assay. Based on the functional results, as well as population and genetic data, we classified 8 variants as likely to be pathogenic and 3 as likely to be benign.
AB - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals out of a cohort of 327 individuals suspected of TSC. A total of 137 predicted pathogenic or likely pathogenic variants were identified: 33 different TSC1 variants in 42 patients, and 104 different TSC2 variants in 126 patients. In 40 cases (24%), the identified predicted pathogenic variant had not been described previously. In total, 33 novel variants in TSC2 and 7 novel variants in TSC1 were identified. To assist in the classification of 11 TSC2 variants, we investigated the effects of these variants in an in vitro functional assay. Based on the functional results, as well as population and genetic data, we classified 8 variants as likely to be pathogenic and 3 as likely to be benign.
KW - Alternative Splicing
KW - Biomarkers, Tumor/genetics
KW - Cohort Studies
KW - DNA Mutational Analysis
KW - Denmark/epidemiology
KW - Humans
KW - Mutation
KW - Tuberous Sclerosis/epidemiology
KW - Tuberous Sclerosis Complex 1 Protein/genetics
KW - Tuberous Sclerosis Complex 2 Protein/genetics
UR - http://www.scopus.com/inward/record.url?scp=85086694324&partnerID=8YFLogxK
U2 - 10.1038/s41598-020-66588-4
DO - 10.1038/s41598-020-66588-4
M3 - Journal article
C2 - 32555378
SN - 2045-2322
VL - 10
SP - 9909
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 9909
ER -